Diabetes Care 25(8):14391443
A rare liver disease, PBC affects around 100,000 people in the U.S
Retatrutide is a research compound that is studied for its benefits in metabolic and endocrinological research
Huster D, Haug F-M, Nagelhus E, Reichelt W, Ottersen OP
940, 941 Basina, M
Ipamorelin adjustments are based on symptoms and lab markers: If sleep and recovery improve at 200 mcg, you may stay at that dose If you want more pronounced GH effects, your physician may increase to 250 to 300 mcg A second daily dose (morning, fasted) can be added for enhanced GH support If water retention or joint stiffness develops, the dose may be reduced Key lab work at the 6 to 8 week mark: IGF-1 (confirms Ipamorelin is producing a GH response) thorough metabolic panel HbA1c and fasting glucose Lipid panel Lab work and monitoring Phase 4: Sustained Progress (Weeks 12 through 24) By this stage, both peptides are dialed in and working together effectively